US Patent Issued to EnGeneIC Molecular Delivery on Sept. 16 for "Compositions comprising bacterially derived minicells and methods of using the same" (Australian Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,968, issued on Sept. 16, was assigned to EnGeneIC Molecular Delivery Pty Ltd (Sydney).

"Compositions comprising bacterially derived minicells and methods of using the same" was invented by Himanshu Brahmbhatt (Sydney) and Jennifer MacDiarmid (Sydney).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods for treating cancer are provided. In particular, the compositions comprise an anti-neoplastic agent and either an interferon type I agonist or an interferon type II agonist, or a combination of an interferon type I agonist and an interferon type II agonist."

The patent was filed on Nov. 18, 2022, under Application No. 17/990,402. ...